Annual Total Liabilities
$126.44 M
+$22.07 M+21.14%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual total liabilities is $126.44 million, with the most recent change of +$22.07 million (+21.14%) on December 31, 2021.
- During the last 3 years, ALBO annual total liabilities has risen by +$63.61 million (+101.25%).
Performance
ALBO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$221.15 M
+$105.81 M+91.74%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly total liabilities is $221.15 million, with the most recent change of +$105.81 million (+91.74%) on September 30, 2022.
- Over the past year, ALBO quarterly total liabilities has increased by +$106.42 million (+92.76%).
Performance
ALBO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALBO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +92.8% |
| 3 y3 years | +101.3% | +216.8% |
| 5 y5 years | +1486.3% | +2673.8% |
ALBO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -48.9% |
| 5 y | 5-year | at high | -43.1% | at high | -68.9% |
| alltime | all time | at high | -99.6% | at high | -99.8% |
Albireo Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $221.15 M(+91.7%) |
| Jun 2022 | - | $115.34 M(+2.0%) |
| Mar 2022 | - | $113.08 M(-10.6%) |
| Dec 2021 | $126.44 M(+21.1%) | $126.44 M(+10.2%) |
| Sep 2021 | - | $114.73 M(+8.2%) |
| Jun 2021 | - | $105.99 M(+4.0%) |
| Mar 2021 | - | $101.90 M(-2.4%) |
| Dec 2020 | $104.38 M(+45.2%) | $104.38 M(+5.1%) |
| Sep 2020 | - | $99.34 M(+4.7%) |
| Jun 2020 | - | $94.89 M(+38.2%) |
| Mar 2020 | - | $68.67 M(-4.5%) |
| Dec 2019 | $71.91 M(+14.5%) | $71.91 M(+3.0%) |
| Sep 2019 | - | $69.82 M(+8.6%) |
| Jun 2019 | - | $64.26 M(+4.3%) |
| Mar 2019 | - | $61.59 M(-2.0%) |
| Dec 2018 | $62.83 M(+688.2%) | $62.83 M(+9.1%) |
| Sep 2018 | - | $57.58 M(+5.3%) |
| Jun 2018 | - | $54.69 M(+3.7%) |
| Mar 2018 | - | $52.73 M(+561.5%) |
| Dec 2017 | $7.97 M(-37.3%) | $7.97 M(-0.0%) |
| Sep 2017 | - | $7.97 M(+7.4%) |
| Jun 2017 | - | $7.42 M(-18.4%) |
| Mar 2017 | - | $9.10 M(+274.3%) |
| Dec 2016 | $12.71 M(+423.0%) | - |
| Sep 2016 | - | $2.43 M(-28.6%) |
| Sep 2016 | $2.43 M(+30.2%) | - |
| Jun 2016 | - | $3.40 M(+7.0%) |
| Mar 2016 | - | $3.18 M(+117.5%) |
| Dec 2015 | - | $1.46 M(-21.7%) |
| Sep 2015 | $1.87 M(-29.0%) | $1.87 M(-30.9%) |
| Jun 2015 | - | $2.70 M(+12.4%) |
| Mar 2015 | - | $2.40 M(+11.4%) |
| Dec 2014 | - | $2.16 M(-17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | $2.63 M(-69.4%) | $2.63 M(-39.9%) |
| Jun 2014 | - | $4.38 M(-24.7%) |
| Mar 2014 | - | $5.82 M(-11.5%) |
| Dec 2013 | - | $6.57 M(-23.5%) |
| Sep 2013 | $8.59 M(-15.1%) | $8.59 M(-30.0%) |
| Jun 2013 | - | $12.27 M(+67.8%) |
| Mar 2013 | - | $7.31 M(-22.1%) |
| Dec 2012 | - | $9.39 M(-7.2%) |
| Sep 2012 | $10.12 M(+128.6%) | $10.12 M(+1.7%) |
| Jun 2012 | - | $9.95 M(+168.3%) |
| Mar 2012 | - | $3.71 M(-20.1%) |
| Dec 2011 | - | $4.64 M(+4.9%) |
| Sep 2011 | $4.43 M(-48.3%) | $4.43 M(-66.6%) |
| Jun 2011 | - | $13.26 M(+156.0%) |
| Mar 2011 | - | $5.18 M(-29.9%) |
| Dec 2010 | - | $7.39 M(-13.6%) |
| Sep 2010 | $8.56 M(-5.8%) | $8.56 M(+67.3%) |
| Jun 2010 | - | $5.11 M(-29.7%) |
| Mar 2010 | - | $7.27 M(+32.9%) |
| Dec 2009 | - | $5.47 M(-39.8%) |
| Sep 2009 | $9.09 M(+0.7%) | $9.09 M(-2.5%) |
| Jun 2009 | - | $9.32 M(+1.7%) |
| Mar 2009 | - | $9.16 M(+15.0%) |
| Dec 2008 | - | $7.96 M(-11.7%) |
| Sep 2008 | $9.02 M(+70.8%) | $9.02 M(+39.2%) |
| Jun 2008 | - | $6.48 M(-5.5%) |
| Mar 2008 | - | $6.86 M(-4.1%) |
| Dec 2007 | - | $7.15 M(+35.4%) |
| Sep 2007 | $5.28 M(+128.6%) | $5.28 M(+54.2%) |
| Jun 2007 | - | $3.43 M(-17.2%) |
| Mar 2007 | - | $4.14 M(+54.3%) |
| Dec 2006 | - | $2.68 M(+16.1%) |
| Sep 2006 | $2.31 M(+327.2%) | $2.31 M(+327.2%) |
| Sep 2005 | $541.00 K | $541.00 K |
FAQ
- What is Albireo Pharma annual total liabilities?
- What is the all time high annual total liabilities for Albireo Pharma?
- What is Albireo Pharma annual total liabilities year-on-year change?
- What is Albireo Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Albireo Pharma?
- What is Albireo Pharma quarterly total liabilities year-on-year change?
What is Albireo Pharma annual total liabilities?
The current annual total liabilities of ALBO is $126.44 M
What is the all time high annual total liabilities for Albireo Pharma?
Albireo Pharma all-time high annual total liabilities is $126.44 M
What is Albireo Pharma annual total liabilities year-on-year change?
Over the past year, ALBO annual total liabilities has changed by +$22.07 M (+21.14%)
What is Albireo Pharma quarterly total liabilities?
The current quarterly total liabilities of ALBO is $221.15 M
What is the all time high quarterly total liabilities for Albireo Pharma?
Albireo Pharma all-time high quarterly total liabilities is $221.15 M
What is Albireo Pharma quarterly total liabilities year-on-year change?
Over the past year, ALBO quarterly total liabilities has changed by +$106.42 M (+92.76%)